Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung disease (ILD) of unknown aetiology, with a median survival of 2–4 years from the time of diagnosis. Although IPF has unknown aetiology by definition, there have been identified several risks factors increasing...
Guardado en:
Autores principales: | Anna Valeria Samarelli, Valentina Masciale, Beatrice Aramini, Georgina Pamela Coló, Roberto Tonelli, Alessandro Marchioni, Giulia Bruzzi, Filippo Gozzi, Dario Andrisani, Ivana Castaniere, Linda Manicardi, Antonio Moretti, Luca Tabbì, Giorgia Guaitoli, Stefania Cerri, Massimo Dominici, Enrico Clini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/de2bff62966847629554c5c69aa0c5db |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of Prognostic Biomarkers Originating From the Tumor Stroma of Betel Quid-Associated Oral Cancer Tissues
por: Yi-Hong Liu, et al.
Publicado: (2021) -
Histological Changes Implicated in Metastasis
por: Díaz-Peña,Roberto, et al.
Publicado: (2014) -
Quantification of Cancer-Developing Idiopathic Pulmonary Fibrosis Using Whole-Lung Texture Analysis of HRCT Images
por: Chia-Hao Liang, et al.
Publicado: (2021) -
Cancer associated-fibroblast-derived exosomes in cancer progression
por: Chao Li, et al.
Publicado: (2021) -
CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
por: Aya Fukuizumi, MD, et al.
Publicado: (2021)